Repligen | أصول متداولة



Current Assets تغيير تاريخ
Agilent USD 4.21B 101M 2025-04
Align Technology USD 2.4B 90.41M 2025-03
Bio Techne USD 627.24M 7.4M 2025-03
BioMarin Pharmaceutical USD 3.47B 235.48M 2025-03
Bristol-Myers Squibb USD 30.78B 1B 2025-03
Bruker USD 2.11B 53.2M 2025-03
Charles River Laboratories USD 1.51B 103.29M 2025-03
Danaher USD 11B 1.47B 2025-06
Dentsply International USD 1.98B 232M 2025-03
Exact Sciences USD 1.37B 201.08M 2025-03
General Electric Aerospace USD 37.8B 226M 2025-06
Henry Schein USD 4.04B 54M 2025-03
Illumina USD 2.67B 73M 2025-03
IQVIA Holdings USD 6.35B 434M 2025-06
Mettler Toledo International USD 1.16B 29.11M 2025-03
Myriad Genetics USD 287.2M 10.8M 2025-03
Pfizer USD 45.86B 4.5B 2025-03
Repligen USD 1.03B 33.58M 2025-03
Revvity USD 2.32B 31.67M 2025-03
Standard Biotools USD 375.88M 77.73M 2024-12
Thermo Fisher Scientific USD 23.38B 1.24B 2025-03
Waters USD 1.74B 70.77M 2025-03
West Pharmaceutical Services USD 1.46B 80.6M 2025-03


Repligen أصول متداولة - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Jul 2025.